- Home
- ABTS vs POAI Comparison
ABTS vs POAI Comparison
Compare ABTS & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- POAI
- Stock Information
- Founded
- ABTS 2010
- POAI 2002
- Country
- ABTS Hong Kong
- POAI United States
- Employees
- ABTS N/A
- POAI N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- POAI Industrial Specialties
- Sector
- ABTS Technology
- POAI Health Care
- Exchange
- ABTS Nasdaq
- POAI Nasdaq
- Market Cap
- ABTS 9.8M
- POAI 8.9M
- IPO Year
- ABTS N/A
- POAI N/A
- Fundamental
- Price
- ABTS $4.03
- POAI $0.89
- Analyst Decision
- ABTS
- POAI Hold
- Analyst Count
- ABTS 0
- POAI 1
- Target Price
- ABTS N/A
- POAI N/A
- AVG Volume (30 Days)
- ABTS 35.8K
- POAI 93.9K
- Earning Date
- ABTS 08-16-2025
- POAI 08-12-2025
- Dividend Yield
- ABTS N/A
- POAI N/A
- EPS Growth
- ABTS N/A
- POAI N/A
- EPS
- ABTS N/A
- POAI N/A
- Revenue
- ABTS $6,711,225.00
- POAI $1,729,269.00
- Revenue This Year
- ABTS N/A
- POAI $486.27
- Revenue Next Year
- ABTS N/A
- POAI $65.50
- P/E Ratio
- ABTS N/A
- POAI N/A
- Revenue Growth
- ABTS 299.11
- POAI 24.17
- 52 Week Low
- ABTS $1.35
- POAI $0.55
- 52 Week High
- ABTS $14.10
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- ABTS 49.53
- POAI 38.00
- Support Level
- ABTS $3.06
- POAI $0.85
- Resistance Level
- ABTS $4.62
- POAI $0.91
- Average True Range (ATR)
- ABTS 0.43
- POAI 0.06
- MACD
- ABTS -0.11
- POAI -0.00
- Stochastic Oscillator
- ABTS 45.55
- POAI 4.12
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.